The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective evaluation of a comprehensive geriatric assessment (CGA) in multidisciplinary bladder cancer care: Feasibility and impact on decisional conflict.
 
Sarah P. Psutka
Honoraria - Prime Education
Consulting or Advisory Role - Nucleix
Research Funding - Prime Education
Travel, Accommodations, Expenses - Prime Education
 
John L. Gore
Research Funding - Ferring
 
Sarah K. Holt
No Relationships to Disclose
 
Erin Dwyer
No Relationships to Disclose
 
George Schade
No Relationships to Disclose
 
Petros Grivas
Consulting or Advisory Role - 4D Pharma; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Dyania Health; EMD Serono; Exelixis; Genentech; GlaxoSmithKline; Guardant Health; Immunomedics; Infinity Pharmaceuticals; Janssen; Merck; Mirati Therapeutics; Pfizer; QED Therapeutics; Regeneron; Roche; Seagen
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); EMD Serono (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Kure It Cancer Research (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); QED Therapeutics (Inst)
 
Andrew Caleb Hsieh
Honoraria - Hotspot Therapeutics
Patents, Royalties, Other Intellectual Property - MTOR modulators and uses thereof Patent number: 9629843; USE OF TRANSLATIONAL PROFILING TO IDENTIFY TARGET MOLECULES FOR THERAPEUTIC TREATMENT Publication number: 20140288097
 
John Kyung Lee
No Relationships to Disclose
 
Robert B. Montgomery
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Beigene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst)
 
Michael Thomas Schweizer
Consulting or Advisory Role - AstraZeneca; PharmaIn; Resverlogix
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); ElevateBio (Inst); Immunomedics (Inst); Immunomedics (Inst); Janssen (Inst); Madison Vaccines, Inc. (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Tmunity Therapeutics, Inc. (Inst); Zenith Epigenetics (Inst)
 
Todd Yezefski
Consulting or Advisory Role - Dendreon
 
Evan Y. Yu
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Clovis Oncology; Exelixis; Janssen; Merck
Research Funding - Bayer (Inst); Blue Earth Diagnostics (Inst); Daiichi Sankyo (Inst); Dendreon (Inst); Lantheus Medical Imaging (Inst); Merck (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Jonathan J. Chen
No Relationships to Disclose
 
Jay Justin Liao
No Relationships to Disclose
 
Emily Steinberger Weg
No Relationships to Disclose
 
Jing Zeng
Honoraria - AstraZeneca; IBA
Consulting or Advisory Role - AstraZeneca
Research Funding - Gilead Sciences
Travel, Accommodations, Expenses - Varian Medical Systems
 
Tristan Alving
No Relationships to Disclose
 
Samia Jannat
No Relationships to Disclose
 
Jonathan L. Wright
Speakers' Bureau - Virginia Mason Medical Center
Research Funding - Altor BioScience; Janssen Oncology; Merck; Nucleix
Patents, Royalties, Other Intellectual Property - Royalties from UpToDate for chapter I wrote.
Other Relationship - Movember Foundation; UpToDate